Sat.Apr 29, 2023 - Fri.May 05, 2023

article thumbnail

Endogena finalises enrolment for retinitis pigmentosa trial

PharmaTimes

The treatment is a small molecule that activates endogenous retinal stem and progenitor cells

104
104
article thumbnail

ChatGPT Outperforms Doctors In Answering Patient Messages, Study Shows

MedCity News

A new study found that ChatGPT might actually be quite successful in providing high-quality answers to patient questions during an era in which doctors and nurses are too busy to do so. The research evaluated two sets of answers to patient inquiries — one written by physicians, the other by ChatGPT. A panel of healthcare professionals determined that ChatGPT’s answers were significantly more detailed and empathetic.

Doctors 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient

PharmaVoice

The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.

Medical 127
article thumbnail

ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win

Fierce Pharma

ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win aliu Wed, 05/03/2023 - 14:50

342
342
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Pharma’s social media problem

Dominic Tyer

Pharma has an opportunity to make more effective - and wider - use of social media, but companies are not currently meeting HCP expectations

Media 130
article thumbnail

Telehealth Companies Applaud DEA for Delaying Telemedicine Restrictions of Controlled Substances

MedCity News

The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back Covid-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities, a decision telehealth companies like Bicycle Health and Mindbloom are in support of.

141
141

More Trending

article thumbnail

Pfizer pulls off Q1 surprise with strong sales even as COVID vaccine demand plummets

Fierce Pharma

Pfizer pulls off Q1 surprise with strong sales even as COVID vaccine demand plummets kdunleavy Tue, 05/02/2023 - 09:27

Sales 312
article thumbnail

Mobile Printer Produces Microneedle Vaccines

Medgadget

Researchers at MIT have developed a printer that can create large numbers of microneedle patch-style vaccines in places where they are needed quickly. Moreover, the printed patches can deliver thermostable mRNA vaccines, whereby the mRNA therapeutic is encapsulated in lipid nanoparticles before printing to enhance its shelf-life at room temperature and avoid the need for cold storage and transport.

article thumbnail

Virtual Primary Care: The New Frontier of Healthcare Delivery [Sponsored]

MedCity News

In an interview, Rob Bressler, general manager for Teladoc Health’s virtual primary care solution Primary360, talked about the company’s shift from telehealth for urgent care to whole person care.

article thumbnail

Astellas Pharma agrees to buy Iveric bio for about $5.9bn

Pharmaceutical Technology

Astellas Pharma has entered into a definitive agreement to buy US-based biopharmaceutical company Iveric bio, in a deal valued at nearly $5.9bn. Under the deal terms, the company, through Astellas US Holding’s wholly owned subsidiary Berry Merger Sub, will acquire all the outstanding Iveric Bio shares for $40.00 in cash for each share. Both the companies’ Boards of Directors have unanimously approved the deal.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

GSK staffers kick off series of strikes in UK for the first time in drugmaker's history

Fierce Pharma

GSK staffers kick off series of strikes in UK for the first time in drugmaker's history aliu Tue, 05/02/2023 - 14:22

295
295
article thumbnail

Graphene Patch Affixes to Heart for Pacemaking

Medgadget

Researchers at Northwestern University and the University of Texas at Austin have developed a thin and flexible graphene “tattoo” that can be affixed to the outside of the heart, and which can monitor heart rhythms and apply corrective electrical impulses to treat arrhythmias. The patch is optically clear, allowing the researchers to also use light to monitor and stimulate the heart.

article thumbnail

VC Identifies 3 Startups That Will Shake Up the Future of Cancer Care

MedCity News

Oncology Ventures recently announced investments in three cancer startups — VivorCare, Gabbi and Health Universe. The fund’s founding partner said each company demonstrated an ability to tackle a specific problem within the cancer care space, such as enabling earlier breast cancer diagnoses and providing personalized care plans for cancer survivors.

Medicine 120
article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. 1,2 In the EU, an estimated 2.7 million people are diagnosed with cancer annually and the number is growing. 3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients.

Patients 105
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Moderna warns of severe sales slowdown in Q2, takes $378M charge amid lull in vaccinations

Fierce Pharma

Moderna warns of severe sales slowdown in Q2, takes $378M charge amid lull in vaccinations aliu Thu, 05/04/2023 - 10:02

Sales 279
article thumbnail

Forge Biologics and Labcorp partner for gene therapies development

Pharmaceutical Technology

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. Gene therapy clients will gain access to coordinated scientific expertise, drug development services and AAV manufacturing capabilities, advancing the development of new gene therapies.

article thumbnail

As Workforce Shortages Intensify, CMS’ Value-based Care Ambitions Hang in the Balance

MedCity News

Absent the ability to bolster their ranks with more clinicians, what rural health centers need first and foremost to shift to value are technologies that amplify their clinical capacity without further burdening and burning out their core staff.

109
109
article thumbnail

Digital transformation to drive biomanufacturing market

European Pharmaceutical Review

A market report has shown that the digital biomanufacturing market is anticipated to grow at a compound annual growth rate (CAGR) of 11 percent between 2023-2035, driven largely by digital transformation. Influencing factors identified in the report include higher competition, competitive pricing and inflation rate, technological advancements and evolving regulatory guidelines.

Marketing 105
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen

Fierce Pharma

Poland takes its COVID-19 vaccine fight to Pfizer's shareholders, urging the company to be a good corporate citizen zbecker Tue, 05/02/2023 - 16:34

241
241
article thumbnail

Taking your biotech global? Here’s how you can navigate cultural norms

PharmaVoice

What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.

Pharma 105
article thumbnail

Is It Possible To Provide Equitable Nutritional Care for Diabetes and Obesity?

MedCity News

With obesity, diabetes, and heart disease rapidly growing among communities of color, we need to do everything we can to help people sustain healthy eating habits. It’ll take more nuance than a Westernized one-size-fits-all diet.

106
106
article thumbnail

Wound Dressing Detects Infection, Changes Color

Medgadget

Researchers at Linköping University in Sweden created a wound dressing that can provide a visual indication if the underlying wound is infected. Chronic wounds are difficult to manage, and presently healthcare staff must remove the dressing regularly to check if an infection is developing. However, this can disrupt the wound by damaging the scab, impairing healing, and may even introduce pathogens in the process.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy

Fierce Pharma

Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy kdunleavy Mon, 05/01/2023 - 07:35

FDA 287
article thumbnail

MIT unlocks real-time powder particle size distribution monitoring

European Pharmaceutical Review

Researchers have developed a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can extract the particle size distribution (PSD) of a pharmaceutical powder surface from its laser speckle. The method provides a real-time, non-invasive, far-field optical probe to monitor particle size distributions quantitatively.

article thumbnail

CVS Health: 60% of Mental Health Physicians See Patients’ Conditions Declining

MedCity News

New CVS Health data found that while 42% of respondents are concerned about their mental health, only 12% are seeing a mental health professional, such as a psychiatrist, psychologist, psychotherapist or wellbeing therapist. Younger respondents are especially struggling: 60% of those aged 18 to 32 years old are concerned about their mental health.

article thumbnail

How To Write Your Medical Sales Resume With Cathy Lanzalaco

Evolve Your Success

Your resume is the key that unlocks the door to your dream job. Invest in it wisely, and let it showcase your unique blend of skills, experience, and potential. With the right words, format, and strategy, you can open doors you never thought possible. In this episode, Samuel Adeyinka sits down with Cathy Lanzalaco. Cathy, who started as a nurse and later transitioned to HR, shares her journey of starting her own business and how she helps people land jobs and build their careers through effectiv

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

J&J's consumer group Kenvue set for $41B IPO, the largest US market debut in more than a year

Fierce Pharma

J&J's consumer group Kenvue set for $41B IPO, the largest US market debut in more than a year esagonowsky Thu, 05/04/2023 - 09:58

Marketing 263
article thumbnail

Transforming oncology with antibody therapeutics

European Pharmaceutical Review

Data announced at the European Lung Cancer Congress (ELCC) earlier this month revealed the long-term efficacy and safety of RYBREVANT ® (amivantamab) in patients with post-platinum EGFR Ex20ins-mutated advanced non-small cell lung cancer (NSCLC). Amivantamab was the first bispecific monoclonal antibody (BsMAb) approved in the EU to treat advanced NSCLC with EGFR exon 20 insertion mutations post chemotherapy.

article thumbnail

Formus Labs’ Hip Surgery Planning Software Expands into the US with FDA Clearance

MedCity News

Formus Labs, a New Zealand-based medical technology startup, has received 510(k) clearance from the FDA for Formus Hip, its fully automated 3D software for hip replacement preoperative planning. The company hopes to start piloting the product at healthcare sites across the U.S. in the next few months.

FDA 112
article thumbnail

Five Years of Forbes | Legacy MEDSearch Ranks on the Forbes Best Executive Recruitment Firms for a Fifth Consecutive Year

Legacy MEDSearch

ORLANDO, Fla., May 3, 2023 – Legacy MEDSearch has been named to the Forbes Best Executive Recruitment Firms and Forbes Best Professional Recruiting Firms out of over 25,000 recruitment and staffing firms in the United States, its fifth consecutive mention since 2019. Forbes Best Recruiting Firms lists are based on votes by industry professionals, who have directly worked with recruiting firms and rankings are earned based on merit.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time